Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study

Gabriele Valentini*, Dörte Huscher, Antonella Riccardi, Serena Fasano, Rosaria Irace, Valentina Messiniti, Marco Matucci-Cerinic, Serena Guiducci, Oliver Distler, Britta Maurer, Jérôme Avouac, Ingo H. Tarner, Marc Frerix, Gabriela Riemekasten, Elise Siegert, László Czirják, Veronika Lóránd, Christopher P. Denton, Svetlana Nihtyanova, Ulrich A. WalkerVeronika K. Jaeger, Francesco Del Galdo, Giuseppina Abignano, Lidia P. Ananieva, Ana Maria Gherghe, Carina Mihai, Joerg Christoph Henes, Tim Schmeiser, Alessandra Vacca, Sergey Moiseev, Ivan Foeldvari, Armando Gabrielli, Brigitte Krummel-Lorenz, Simona Rednic, Yannick Allanore, Ulf Müeller-Ladner

*Corresponding author for this work
8 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study'. Together they form a unique fingerprint.

INIS